FDA cancels Cipla Pune unit's licence over Reactin Plus violations; firm contests - India Today
The cancellation came into effect on August 27, following an inspection of the company's main warehouse at Wadki in Pune district, according to the FDA.
Ähnliche Seiten
Maharashtra FDA Cancels Drug Sale Licences Of Cipla Pharma & Life Sciences’ Pune C&F Unit Over Reactin Plus Irregularities
Tukaram Mundhe cracks down: Maharashtra FDA cancels licence of Cipla's Pune unit over regulatory violations, Cipla contests action - The Economic Times